학술논문

Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HRD HER2L metastatic breast cancer patients receiving palbociclib and endocrine therapy: primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trial
Document Type
Journal
Source
ANNALS OF ONCOLOGY; AUG 2023, 34 8, p660-p669, 10p.
Subject
Language
English
ISSN
15698041